INCY
NASDAQ HealthcareIncyte Corporation - Common Stock
Biotechnology
📊 Market Data
| Price | $92.03 |
|---|---|
| Volume | 1,871,815 |
| Market Cap | 18.32B |
| Beta | 0.840 |
| RSI (14-Day) | 21.3 Oversold |
| 200-Day MA | $88.86 |
| 50-Day MA | $101.77 |
| 52-Week High | $112.29 |
| 52-Week Low | $53.56 |
| P/E Ratio | 14.36 |
| Forward P/E | 10.61 |
| Price / Book | 3.53 |
🎯 Investment Strategy Scores
How INCY scores across each investment strategy. Higher is better for that strategy's goals.
💰 Dividend Daddy
37/100
High dividend yield + low volatility
🚀 Moon Shot
62/100
High growth potential (high beta + oversold)
🔪 Falling Knife
65/100
Contrarian plays (oversold + below moving average)
🎈 Over-Hyped
15/100
Overbought stocks (potential short candidates)
🐋 Institutional Whale
81/100
Large-cap, institutional-quality stocks
Find INCY in your text
Paste any text on the homepage — the tool will extract INCY and other hidden tickers.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.